vimarsana.com

Latest Breaking News On - Priya singhal - Page 1 : vimarsana.com

Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition

Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Stockholm
Sweden
Priya-singhal
William-blair
Myles-minter
Reata-pharmaceuticals
European-renal-association-congress
Novartis
Vertex-pharmaceuticals
Alpine-immune-sciences
Human-immunology-biosciences
Chinook-therapeutics

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute

BOSTON, MA / ACCESSWIRE / May 23, 2024 / Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood

Dana-farber-cancer-institute
Massachusetts
United-states
Boston
Jake-auchincloss
Sally-kornbluth
Arielle-jackson
Peter-marks
Brian-goff
Stephen-hoge
Laurie-glimcher
Deborah-dunsire

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought ...

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Dana-farber-cancer-institute
Massachusetts
United-states
Boston
Chris-viehbacher
Jake-auchincloss
Mathai-mammen
Peter-marks
Al-sandrock
Rochelle-walensky
Bob-langer
Arielle-jacksondirector

Biogen Buys Biotech Firm HI-Bio to Boost Its Immunology Portfolio

Biogen has agreed to pay at least $1.15 billion for biotech firm Human Immunology Biosciences as it moves to increase its immunology portfolio.

Priya-singhal
Head-of-development-at-biogen
Human-immunology-biosciences

Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition

Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Priya-singhal
Reata-pharmaceuticals
Drug-administration
Biogen-idec
Human-immunology-biosciences
San-francisco-bay-area
Breakthrough-therapy-designation
Orphan-drug-designation
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.